You are using an older browser version. Please use a supported version for the best MSN experience.

Oxford University Resuming Vaccine Trial After Side Effect Detected

The drug being developed by Oxford and AstraZeneca is considered a leading contender as a potential COVID-19 vaccine.
image beaconimage beaconimage beacon